. . . . . "casirivimab" . . . "Indevimab" . . . "COVID-19" . . . "SARS-CoV-2 infection" . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . "2022-10-13T12:08:46.697156"^^ . . "Indevimab is used only with casirivimab to prevent COVID-19 from laboratory-confirmed SARS-CoV-2 infection in patients aged 12 years of age and older who weigh at least 40 kg. Treatment is reserved for patients who are at high risk for progressing to require hospitalization or severe treatment. This combination may only be administered by intravenous infusion in healthcare settings with immediate access to treatment." . "2.3.0" . "RSA" . "MIIBIjANBgkqhkiG9w0BAQEFAAOCAQ8AMIIBCgKCAQEApdULbl+/+pkVlq0fAzWmzfgIb+XMuQPKHMDVzUTWCZBjLfzORll42ptr52e4w7tTYkUKrBsQbx8lkjZWAlWiyh+xIK0oLFSdYRSt63kgiyRYBUOR+spcgmofb7f6JyftArPVTKhsWOMt/mcyNG9qc3lw8B/xuPmLteUWO33xWhfXQreTw1lsGUkZ1j4cB4X9HIuI20ktLYLCXaBauNHEJZ4qp6/Q2ATsJcw8tg7aRmFKXhrjM9maZ2+0cMg0Jpmn2UnDlPKXEA6Qq+qnvvQt8KFjIzP9FTMyvrWl8tTd0NCmS9VpooZJQ8We1lGMPXg5bMbe/bVkTf70fbFMf0RKrQIDAQAB" . "G2xmd7kiOH2nzVIsoyez913EC7D4BcyoyIavt0Uz8FKZuXFnWtfTM4y+Qggl2Jy5bp/gYMcPt56rkNyRwjhXTn+d7uilkNJQzl42VWsnXnvr71l5MCzUZIikREa0hhpbTp1vOc94hiK/GpJUzMSqx9o0Tn1oO3BaSbgvLChUZ2e9CDwI4THhx+M2NbWoKlu2UAv85abgfvchHQX7QUgF1Lr8k6CyX+WN2Fcm1mSyNu2fqtdc34M66LfF/gJGTDWLGOMjM2ulZD4U52Pr8zIPtD1PmJLeii8aB2D1KettL8ty8V58qvO/XknOm/SNSsWXzBf5pfCk+sndzVcipS/9bg==" . . "2022-10-13T12:08:46.697156"^^ . .